Supported by

Tricuspid / Pulmonary valve

Latest tricuspid content in interventional cardiology - research, practice, and education

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

519 results

Structural and Valvular Interventions: EuroPCR 2025 highlights

22 May 2025 – From EuroPCR 2025

Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...

Structural: EuroPCR 2025 highlights

Tricuspid hotline: new devices

22 May 2025 – From EuroPCR 2025

Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.

Tricuspid hotline: new devices

Assessment and management of patients with multivalvular disease involving the tricuspid valve

22 May 2025 – From EuroPCR 2025

Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.

Assessment and management of patients with multivalvular disease involving the tricuspid valve

Optimising TEER in challenging anatomies

22 May 2025 – From EuroPCR 2025

Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.

Optimising TEER in challenging anatomies

Challenging tricuspid TEER cases

22 May 2025 – From EuroPCR 2025

Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.

Challenging tricuspid TEER cases

Predictors outcome after tricuspid TEER: is there a perfect tool

22 May 2025 – From EuroPCR 2025

Examine predictors of outcome following tricuspid transcatheter edge-to-edge repair (TEER) in this focused session. Review meta-analyses on TEER efficacy, survival benefits in high-risk patients from the EuroTR registry, and prognostic value of MELD?XI score from the TRISPA registry. Learn about TRI.Fr eligibility criteria and validation of...

Predictors outcome after tricuspid TEER: is there a perfect tool

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

21 May 2025 – From EuroPCR 2025

Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

Enhancing clipping solutions for durable long-term patient outcomes

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...

Enhancing clipping solutions for durable long-term patient outcomes

The many faces of TTVR

21 May 2025 – From EuroPCR 2025

Discover the diverse clinical scenarios of transcatheter tricuspid valve replacement (TTVR). This session presents complex cases including acute right ventricular afterload mismatch, combined pulmonary and tricuspid valve interventions in carcinoid heart disease, and challenges in dilated cava anatomy, showcasing the expanding frontiers of TTVR therapy.

The many faces of TTVR